Funding you earn now, next payment 02:00 UTC+0.0220%/8h= +24.1% APRpaid last 24h +0.066%
Price spread now: Injective against Bybit+9.933%98s7-day average — · you sell dearer than you buy
to open and closeno order booka leg has no order-book sample
Funding, last 4 days (all we have)—no history yet
+Price spread, last 7 days—no price history on both exchanges yet
=Together, before fees—needs both histories
Both sides work for this trade now. Funding pays +$7 a day on $10k at the current rate, and Injective is 9.933% dearer against Bybit than usual: you sell high and buy low: +$993 more if the spread goes back to zero (this spread has no 7-day history yet). The two prices were read 98 seconds apart, so part of this spread may be the market moving, not a spread.
| Leg | Exchange | Price | Funding /8h | Each payment | Next in | OI | Vol 24h | Max lev |
|---|---|---|---|---|---|---|---|---|
| Long | Bybit AMGNUSDT | 393.02 | 0 | get 0.0000% / 8h | 6h 21m | $85K | $14K | 25x |
| Short | Injective AMGN/USDC PERP | 432.06 | 0.0220 | get 0.0028% / 1h | 21m 43s | $11K | $19K | 12x |
Funding history
latest
Range statsloading…
Price spread between the two exchanges
Injective against Bybit. Falling: the short leg gains. Rising: it loses.latest
Price spreadloading…
Funding on every exchange
click an exchange to add or hide itlatest
How often the price spread is this wide · share of time at each level, last 7D show
Profit calculator
- Funding earned
- $46.2
- Price spread: +9.933% → 0.000%
- $993.33
- Slippage, 4 orders
- no order book: not counted
- Fee Bybit: 5.5 bp × 2 orders
- −$11
- Fee Injective: 0.01 bp × 2 orders
- −$0.02
- Net
- $1,028.51
- Costs to cover
- 0.110%
- Break-even
- from the start
Slippage unknown: Bybit: no order-book sample; Injective: no order-book sample. Net counts fees only.
Cost to enter
taker fee + slippage from the mid, one side; closing costs about the same again| Leg | Half-spread | $10k | $100k | $1M | $5M |
|---|---|---|---|---|---|
| Buy Bybit no order-book sample | — | — | — | — | — |
| Sell Injective no order-book sample | — | — | — | — | — |
Bybit and Injective: no order-book sample. Either the market is below $100k of open interest and volume (not sampled), or the venue executes at an oracle price and its slippage is not modeled here: see the venue's docs.
AMGN on 6 venues
lowest funding first. Swap a leg: a good short leg pays more funding and is priced higher.| Exchange | Funding /8h | Every | Price | Price vs long leg | OI | Vol 24h | Max lev | |
|---|---|---|---|---|---|---|---|---|
| Bybit AMGNUSDTlong | 0.0000% | 8h | 393.02 | long leg | $85K | $14K | 25x | |
| Gate AMGN_USDT | 0.0000% | 8h | 393.80 | +0.198% | $60K | $2K | 20x | as long as short |
| Bitget AMGNUSDT | 0.0000% | 8h | 392.77 | −0.064% | $57K | $46K | 20x | as long as short |
| HTX AMGN-USDT | 0.0000% | 8h | 393.70 | +0.173% | $5K | $297K | 20x | as long as short |
| Extended AMGN-USD | +0.0040% | 1h | 392.70 | −0.082% | $20K | — | 10x | as long as short |
| Injective AMGN/USDC PERPshort | +0.0220% | 1h | 432.06 | +9.933% | $11K | $19K | 12x |
Bybit AMGNUSDT
Injective AMGN/USDC PERP
Gate AMGN_USDT
Bitget AMGNUSDT
HTX AMGN-USDT
Extended AMGN-USD